Iterum Therapeutics Plc (ITRM) Tops Q1 EPS by 60c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.58), $0.60 better than the analyst estimate of ($1.18).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan